ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Big data"

  • Abstract Number: 821 • 2019 ACR/ARP Annual Meeting

    Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD)

    Subhashisa Swain1, Aliya Sarmanova 2, Christian Mallen 3, Chang Fu Kuo 4, Carol Coupland 5 and Weiya Zhang 6, 1University of Nottingham, Nottingham, England, United Kingdom, 22. Bristol Medical School, Population Health Sciences, University of Bristol, UK, Bristol, England, United Kingdom, 3Research Institute for Primary Care and Health Sciences, Keele University, UK, Keele, United Kingdom, 44. Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan (Republic of China), 55. Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, England, United Kingdom, 61. Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, England, United Kingdom

    Background/Purpose: Osteoarthritis (OA) is by far the most common arthritis.(1) However,  its chronological trend in the United Kingdom (UK) is not known. We aimed to…
  • Abstract Number: 1113 • 2019 ACR/ARP Annual Meeting

    Improving Healthcare Quality and Reducing Cost via Online Interaction for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tool

    Hua Wei1, Anbin Huang 2, Li Luo 3, Fen Wang 4, Qin Li 5, Hong Zhang 6, Yong Wang 7, Peng Ji 3, Yanping Zhao 8, LingXun Shen 9, Zhengang Wang 10, Feng Wei 11, Tong Xie 12, Xiaohan Wang 13, Huifang Guo 14, Qiang Shu 15, Xiangyuan Liu 16, Rong Du 17, Anbing Zhang 18, Fang Qin 19, Bing Wu 20, Yuhua Jia 21, Hui Xiao 22, Fei Xiao 23 and Fengchun Zhang 24, 1Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 2Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technolog, Han Wu, Hubei, China (People's Republic), 3The first affiliated hospital of xinjiang medical university, Urumchi, China (People's Republic), 4First Affiliated Hospital of Medical University Of Anhui, Hefei, Anhui, China (People's Republic), 5The First People's Hospital of Yunnan Province, Kunming, Yunnan, China (People's Republic), 6The First People's Hospital of Yunnan Province, Kunming, China (People's Republic), 7The first Hospital Affiliated to AMU (Southernwest Hospital), Chongqing, China (People's Republic), 8First Affiliated Hospital of Harbin Medical University, Harbin, China (People's Republic), 9Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (People's Republic), 10TongRen hospital,Capital University, Bei Jing, China (People's Republic), 11Jiangmen Central Hospital Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China (People's Republic), 12Affiliated hospital of Guangdong medical University, Zhanjiang, Guangdong, China (People's Republic), 13Anyang district hospital, Fuyang, Hainan, China (People's Republic), 14The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), 15Qilu Hospital of Shandong University, Jinan, China (People's Republic), 16Peking University Third Hospital, Beijing, China (People's Republic), 17Union hospital affiliated to huazhong university of science and technology, Wuhan, China (People's Republic), 18Xiangyang city center hospital, Xiangyang, China (People's Republic), 19The first affiliated hospital of guangxi medical university, Nanning, China (People's Republic), 20Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), 21Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 22Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), 23Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic), 24Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (People's Republic)

    Background/Purpose: Without efficient primary medical care and follow-up system in China, patients can choose any hospital or doctor they like in seeking medical care. As…
  • Abstract Number: 1208 • 2019 ACR/ARP Annual Meeting

    Outpatient Readmission in Rheumatology: A Machine Learning Predictive Model of Patient’s Return to the Clinic

    Luis Rodríguez-Rodríguez1, Alfredo Madrid García 1, Judit Font Urgelles 2, Mario Vega-Barbas 3, Leticia León 4, Dalifer Freites Nuñez 5, Cristina Lajas 6, Esperanza Pato Cour 6, Juan Angel Jover Jover 6, Benjamín Fernández Gutiérrez 7 and lydia Abasolo Alcazar 6, 1Fundación para la Investigación Biomedica, Madrid, Spain, 2HOSPITAL CLINICO SAN CARLOS, MADRID, Madrid, Spain, 3Universidad Politécnica de Madrid, Madrid, Madrid, Spain, 4Fundación para la Investigación Biomedica, Madrid, Madrid, Spain, 5Hospital Clínico San Carlos, MADRID, Spain, 6HOSPITAL CLINICO SAN CARLOS, MADRID, Spain, 7Hospital Clínico San Carlos, Madrid

    Background/Purpose: Readmissions can be defined as the return of a patient to a healthcare setting after a discharge. Attention has been mainly focused on readmissions…
  • Abstract Number: 1370 • 2019 ACR/ARP Annual Meeting

    Not All Joints Are Equal: Challenge DAS28 System and Identify Factors Leading to a Mismatch Between T2T and HAQ Among RA Patients Through Data Mining from Smart System of Disease Management (SSDM)

    Jing Yang1, Zhenbiao Wu 2, Yongfu Wang 3, Hua Wei 4, Yu Zhang 1, Xiaoling Liu 5, Xiaofeng Rong 6, Jinmei Zou 1, Xiaofei Shi 7, Hongbin Li 8, Rui Wu 9, Xiaoli Deng 10, Huiqiong Zhou 11, Yuan Jia 12, Wei Zhao 13, Shi Chen 12, Xuewu Zhang 12, Yingnan Li 14, Yingkun Nie 14, Yifang Mei 15, Jianyu Zhang 16, Hanyou Mo 17, li Sun 18, Yanfei Chen 19, Haili Shen 20, Dongsheng Li 21, Yonggang Zhao 22, Hui Xiao 23, Bing Wu 24, Yuhua Jia 22 and Fei Xiao 25, 1Central Hospital of MianYang, Mianyang, Sichuan, China (People's Republic), 2The First Affiliated Hospital of The Fourth Military Medical University, Xian, Shanxi, China (People's Republic), 3The First Affiliated Hospital of BaoTou Medical College, Baotou, Nei Mongol, China (People's Republic), 4Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 5The 1st Affiliated Hospital of Guangzhou University of TCM, Guangzhou, China (People's Republic), 6The 1st Affiliated hospital of Chongqing medical University, Chongqing, Chongqing, China (People's Republic), 7First Affiliated Hospital of Henan University of Science and Technology, luoyang, Henan, China (People's Republic), 8The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Nei Mongol, China (People's Republic), 9The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (People's Republic), 10Peking University Third Hospital, Beijing, Beijing, China (People's Republic), 11Fourth Medical Center of PLA Genal Hospital, Beijing, Beijing, China (People's Republic), 12Peking University People's Hospital, Beijing, Beijing, China (People's Republic), 13Chinese PLA General Hospital, Beijing, Beijing, China (People's Republic), 14The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (People's Republic), 15The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (People's Republic), 16The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China (People's Republic), 17Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China (People's Republic), 18The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (People's Republic), 19The First Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), 20The Second Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), 21Ganzhou People's Hospital, Ganzhou, Jiangxi, China (People's Republic), 22Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 23Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), 24Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), 25Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)

    Background/Purpose: Treat to target (T2T), achieving a DAS28 score lower than 3.2, is the strategy recommended by ACR and EULAR. Health assessment questionnaire (HAQ) is…
  • Abstract Number: 1371 • 2019 ACR/ARP Annual Meeting

    Create an Algorithm of Outcome Forecasting and Decision Making for RA Treatment: Data Mining and Machine Learning via the Smart System of Disease Management (SSDM)

    Rong Mu1, Chun Li 2, Jing Yang 3, Xiaohan Wang 4, Bin Wu 5, Fengxiao Zhang 6, Yong Wang 7, Li Qin 8, Cundong Mi 9, Huifang Guo 10, Wei Wei 11, Wei Liu 12, Qingchun Huang 13, Jing Lu 14, Yang Liu 15, Huiling Li 16, Bing Wu 17, Hui Xiao 18, Yuhua Jia 19 and Fei Xiao 20, 1People's Hospital, Beijing University Medical School, Beijing, China (People's Republic), 2People's Hospital, Beijing University Medical School, Beijing, Beijing, China (People's Republic), 3Central Hospital of MianYang, Mianyang, Sichuan, China (People's Republic), 4Anyang district hospital, Fuyang, Hainan, China (People's Republic), 5Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China (People's Republic), 6Hebei General Hospital, Shijiazhuang, Hebei, China (People's Republic), 7The first Hospital Affiliated to AMU (Southernwest Hospital), Chongqing, China (People's Republic), 8The No.3 People’s Hospital of HuZhou City, Huzhou, Zhejiang, China (People's Republic), 9The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (People's Republic), 10The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), 11Tianjin Medical University General Hospital, Tianjin, Tianjin, China (People's Republic), 12First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (People's Republic), 13The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China (People's Republic), 14First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China (People's Republic), 15Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Nei Mongol, China (People's Republic), 16Hubei Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China (People's Republic), 17Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), 18Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), 19Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 20Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)

    Background/Purpose: Daily health care deals with a wide spectrum of RA patients from statuses of remission (R) to disease activities at low (L), moderate (M)…
  • Abstract Number: 2060 • 2019 ACR/ARP Annual Meeting

    The Current State of Big Data Use and Artificial Intelligence in RMDs: A Systematic Literature Review Informing EULAR Recommendations

    Joanna Kedra1, Timothy R.D. Radstake 2, Aridaman Pandit 3, Xenofon Baraliakos 4, Francis Berenbaum 5, Axel Finckh 6, Bruno Fautrel 7, Tanja Stamm 8, David Gomez-Cabrero 9, Christian Pristipino 10, Remy Choquet 11, Hervé Servy 12, Simon Stones 13, Gerd Burmester 14 and Laure Gossec 15, 1Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), UMR S1136, Paris France, Paris, France, 2Department of Rheumatology/Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Utrecht, Netherlands, 3Dept. of Rheumatology, Clinical Immunology and Laboratory for Translational Immunology, University Medical Center Utrecht, The Netherlands, Utrecht, Netherlands, 4Rheumazentrum Ruhrgebiet-Ruhr-University Bochum, Herne, Germany, Herne, Germany, 5Sorbonne Université-Inserm CDR Saint-Antoine, AP-HP, Paris, France, 6Division of Rheumatology, Geneva University Hospital, Switzerland, Geneva, Switzerland, 7Pitié-Salpêtrière Hospital, Department of Rheumatology, AP-HP, Sorbonne University, UPMC university, Paris, Ile-de-France, France, 8Medical University of Vienna, Vienna, Austria, 9Translational Bioinformatics Unit, Navarra Biomed, Departamento de Salud-Universidad Pública de Navarra, Pamplona, Navarra, Spain, Pamplona, Spain, 10Ospedale San Filippo Neri, Rome, Italy., Rome, Italy, 11INSERM U1142, Orange Healthcare, France, Paris, France, 12Sanoia e-health services, France, Paris, France, 13School of Healthcare, University of Leeds, Leeds, UK, Leeds, United Kingdom, 14Charité—University Medicine Berlin, Berlin, Germany, 15Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France

    Background/Purpose: Big data are defined as data sets that are too large or complex for traditional data-processing application software to adequately deal with. Artificial Intelligence…
  • Abstract Number: 2071 • 2019 ACR/ARP Annual Meeting

    The Prevalence of 78 Autoimmune Diseases in Catalonia (MASCAT-PADRIS Big Data Project)

    Soledad Retamozo1, Antoni Sisó-Almirall 2, Belchin Kostov 3, Elisenda Martínez-Carbonell 4, Pilar Brito-Zerón 5, Pere Blanch Ramirez 6, Nihan Acar-Denizli 7, Pedro Delicado 6, Susana González-Martínez 8, César Velasco Muñoz 4, Jaume Benavent Àreu 9 and Manuel Ramos-Casals 10, 1Instituto De Investigaciones En Ciencias De La Salud, Univ. Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto Universitario de Ciencias Biomédicas de Córdoba, Córdoba, Argentina., Cordoba, Argentina, 2Primary Healthcare Transversal Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Primary Care Centre Les Corts, Consorci d’Atenció Primària de Salut Barcelona Esquerra (CAPSBE). Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain., Barcelona, Spain, 3Primary Healthcare Transversal Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Primary Care Centre Les Corts, Consorci d’Atenció Primària de Salut Barcelona Esquerra (CAPSBE). Department of Statistics and Operations Research, Universitat Politècnica de Catalunya, Barcelona, Spain., Barcelona, Spain, 4Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQUAS), Barcelona, Spain., Barcelona, Spain, 5Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, University of Barcelona, Hospital Clínic. Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona, Spain., Barcelona, Spain, 6Department of Statistics and Operations Research, Universitat Politècnica de Catalunya, Barcelona, Spain., Barcelona, Spain, 7Department of Statistics, Faculty of Science and Letters, Mimar Sinan Fine Arts University, Istanbul, Turkey., Istanbul, Turkey, 8Primary Care Centre Les Corts, Consorci d’Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain., Barcelona, Spain, 9Primary Healthcare Transversal Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Primary Care Centre Les Corts, Consorci d’Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain., Barcelona, Spain, 10Department of Autoimmune Diseases, ICMiD. Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX. Department of Medicine, University of Barcelona, Hospital Clínic, Barcelona, Spain., Barcelona, Spain

    Background/Purpose: To analyze the prevalence of autoimmune diseases (ADs) in Catalonia, a Mediterranean region with nearly 8 million inhabitants using a public administrative big data…
  • Abstract Number: 1252 • 2018 ACR/ARHP Annual Meeting

    Screening for Tuberculosis before Initiating TNF Inhibitors: How Well Do We Do? a Nationwide Experience

    Karim Ladak1, Ting Pan2 and Catherine MacLean1, 1Rheumatology, Hospital For Special Surgery, New York, NY, 2Value Office, Hospital For Special Surgery, New York, NY

    Background/Purpose: Tumor necrosis factor inhibitors (TNFi) revolutionized treatment of various conditions, however they drastically increase the risk of latent tuberculosis (LTBI) reactivation. Many national medical…
  • Abstract Number: 1686 • 2018 ACR/ARHP Annual Meeting

    Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data

    Anika S. Ghosh1, Theresa L. Walunas2, Kathryn L. Jackson1, Ahn H. Chun3, Daniel L. Erickson3, Karen Mancera-Cuevas4, Abel N. Kho3 and Rosalind Ramsey-Goldman5, 1Center for Health Information Partnerships, Northwestern University, Chicago, IL, 2Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4Rheumatology, Northwestern University, Chicago, IL, 5FSM, Northwestern University, Chicago, IL

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and…
  • Abstract Number: 2802 • 2018 ACR/ARHP Annual Meeting

    Risk of Ischemic Stroke in Veterans with Systemic Sclerosis: A Nationwide Cohort Study

    David Ying1,2, Milena Gianfrancesco1, Laura Trupin1, Jinoos Yazdany1, Eric Greidinger3,4 and Gabriela Schmajuk2,5, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2San Francisco VA Medical Center, San Francisco, CA, 3Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL, 4Miami VA Medical Center, Miami, FL, 5Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA

    Background/Purpose: Previously thought to involve primarily the microvasculature, systemic sclerosis (SSc) has been increasingly linked to macrovascular disease. Cardiovascular and cerebrovascular disease are responsible for…
  • Abstract Number: 1014 • 2017 ACR/ARHP Annual Meeting

    The Rheumatic Disease Data Refinery: A Case Study in Integrative Genomics Reveals Complex IFN Signatures in Therapeutic Studies in SLE

    Jaclyn N Taroni and Casey S. Greene, Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Over the past 15 years, more than 10,000 whole tissue biopsies from patients with rheumatic diseases have been deposited into publicly available gene expression…
  • Abstract Number: 1170 • 2017 ACR/ARHP Annual Meeting

    High Output Flow Cytometry Array Classifies Subjects with Uveitis Due to Behcet’s Disease and Sarcoidosis

    Johannes Nowatzky1, Ezra Resnick2, Julia Manasson3, Cristy Stagnar1 and Olivier Manches4, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2Google Inc., New York, NY, 3Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4EFS Rhône-Alpes-Auvergne "Immunobiology and Immunotherapy in Chronic Diseases", INSERM - French National Institute of Health and Medical Research, Grenoble, France

    Background/Purpose: The information content of multi-parametric flow cytometry-based immune-phenotyping experiments is routinely underexploited given the paucity of adequate tools and strategies for large-scale unbiased data…
  • Abstract Number: 1234 • 2017 ACR/ARHP Annual Meeting

    How Machine Learning Statistics Can Change the Game of Data Analysis in Rheumatology: The Example a Study with 170 Patients with Rheumatoid Arthritis (ra) or Axial Spondyloarthritis (axspa)

    Frédéric Guyard1, Laure Gossec2, Didier Leroy3, Thomas Lafargue1, Michel Seiler3, Charlotte Jacquemin4, Anna Molto5, Jeremie Sellam6, Violaine Foltz4, Frédérique Gandjbakhch4, Christophe Hudry7, Stéphane Mitrovic4, Bruno Fautrel4 and Herve Servy8, 1IMT, Orange, Nice, France, 2UPMC, University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 3Healthcare, Orange, Paris, France, 4UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 5Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, 6Rheumatology, Saint-Antoine Hospital, Paris, France, 7AP-HP Hôpital Cochin, Paris, France, 8e-health services, Sanoia, Gemenos, France

    Background/Purpose: A link between flares and physical activity would confirm the objective consequences of flares. In the ActConnect study of patients with RA or axSpA,…
  • Abstract Number: 2609 • 2017 ACR/ARHP Annual Meeting

    A Systematic Literature Mining and Gene Expression Analysis Identifies Possible Drug Candidates for Repositioning in Lupus

    Peter E. Lipsky, Matt Ryals, Adam Labonte, Sarah Heuer, James Dittman, Michelle Catalina and Amrie Grammer, AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA

    Background/Purpose: Since new therapies for lupus have been extremely slow to develop and lupus patients have a great unmet medical need, an independent pharma-external effort…
  • Abstract Number: 337 • 2017 ACR/ARHP Annual Meeting

    Patient-Reported Flares Were Correctly Predicted By an Algorithm Using Machine-Learning Statistics on Activity Tracker Data on Steps, in a Longitudinal 3-Month Study of 170 Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA)

    Laure Gossec1, Frédéric Guyard2, Didier Leroy3, Thomas Lafargue2, Michel Seiler3, Charlotte Jacquemin1, Anna Molto4, Jeremie Sellam5, Violaine Foltz1, Frédérique Gandjbakhch1, Christophe Hudry6, Stéphane Mitrovic1, Bruno Fautrel1 and Herve Servy7, 1UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 2IMT, Orange, Nice, France, 3Healthcare, Orange, Paris, France, 4Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, 5Rheumatology, Saint-Antoine Hospital, Paris, France, 6AP-HP Hôpital Cochin, Paris, France, 7e-health services, Sanoia, Gemenos, France

    Background/Purpose: The natural history of RA and axSpA comprises periods of low disease activity and flares. However, there are few data linking patient-reported flares to…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology